Hnp Capital LLC Dexcom Inc Transaction History

Hnp Capital LLC

$356 Million
Q1 2023

A detailed history of Hnp Capital LLC transactions in Dexcom Inc stock. As of the latest transaction made, Hnp Capital LLC holds 13,901 shares of DXCM stock, worth $965,980. This represents 0.45% of its overall portfolio holdings.

Number of Shares

13,901

Previous 14,337 3.04%

Holding current value

$965,980

Previous $1.62 Million 0.49%

% of portfolio

0.45%

Previous 0.46%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 18, 2023	SELL	$104.0 - $122.92 $45,344 - $53,593	-436 Reduced 3.04%	13,901 $1.62 Million
Q4 2022 Jan 24, 2023	SELL	$84.98 - $122.67 $159,762 - $230,619	-1,880 Reduced 11.59%	14,337 $0
Q3 2022 Oct 18, 2022	SELL	$76.35 - $94.18 $9,849 - $12,149	-129 Reduced 0.79%	16,217 $1.31 Million
Q2 2022 Jul 20, 2022	BUY	$67.99 - $132.89 $830,361 - $1.62 Million	12,213 Added 295.5%	16,346 $1.22 Million
Q1 2022 Aug 15, 2022	BUY	$94.08 - $130.2 $388,832 - $538,116	4,133 New	4,133 $2.11 Million
Q1 2022 May 02, 2022	SELL	$94.08 - $130.2 $374,908 - $518,846	-3,985 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$129.87 - $162.82 $11,688 - $14,653	90 Added 2.31%	3,985 $2.14 Million
Q3 2021 Oct 14, 2021	BUY	$106.71 - $143.18 $13,018 - $17,467	122 Added 3.23%	3,895 $2.13 Million
Q2 2021 Jul 14, 2021	BUY	$80.99 - $107.93 $15,307 - $20,398	189 Added 5.27%	3,773 $1.61 Million
Q1 2021 May 28, 2021	BUY	$84.79 - $104.74 $30,439 - $37,601	359 Added 11.13%	3,584 $1.29 Million
Q4 2020 Feb 10, 2021	BUY	$78.0 - $104.5 $30,732 - $41,173	394 Added 13.92%	3,225 $1.19 Million
Q3 2020 Nov 09, 2020	BUY	$95.51 - $112.95 $82,425 - $97,475	863 Added 43.85%	2,831 $1.02 Million
Q2 2020 Jul 06, 2020	BUY	$62.68 - $105.34 $123,354 - $207,309	1,968 New	1,968 $802,000

Others Institutions Holding DXCM

# of Institutions

1,111

Shares Held

365M

Call Options Held

4.1M

Put Options Held

3.65M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hnp Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hnp Capital LLC with notifications on news.

Account